| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14712598.2011.578574 |
| P698 | PubMed publication ID | 21542780 |
| P50 | author | Udi Sarig | Q51081343 |
| P2093 | author name string | Marcelle Machluf | |
| P2860 | cites work | Biomaterials for the Treatment of Myocardial Infarction | Q22252426 |
| Evidence for cardiomyocyte renewal in humans | Q24594522 | ||
| Collagen structure and stability | Q24610632 | ||
| Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells | Q24644294 | ||
| Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue | Q24652369 | ||
| Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts | Q27323532 | ||
| Bone marrow cells regenerate infarcted myocardium | Q28210640 | ||
| Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration | Q28240250 | ||
| Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha | Q28259513 | ||
| Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart | Q28264555 | ||
| Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes | Q28345594 | ||
| Medium perfusion enables engineering of compact and contractile cardiac tissue | Q28564386 | ||
| Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors | Q28589872 | ||
| Generation of mouse induced pluripotent stem cells without viral vectors | Q29614342 | ||
| Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts | Q29614794 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts | Q29620480 | ||
| Electrical stimulation systems for cardiac tissue engineering. | Q30491543 | ||
| Microfabricated poly(ethylene glycol) templates enable rapid screening of triculture conditions for cardiac tissue engineering | Q42813852 | ||
| A tough biodegradable elastomer | Q42814492 | ||
| Tumourigenesis in the infarcted rat heart is eliminated through differentiation and enrichment of the transplanted embryonic stem cells | Q42917456 | ||
| Human bone marrow-derived CD133(+) cells delivered to a collagen patch on cryoinjured rat heart promote angiogenesis and arteriogenesis | Q43071875 | ||
| Intracardiac allogeneic mesenchymal stem cell transplantation elicits neo-angiogenesis in a fully immunocompetent ischaemic swine model. | Q43077753 | ||
| Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells. | Q43108108 | ||
| Injectable hydrogel helps bone marrow-derived mononuclear cells restore infarcted myocardium | Q43166728 | ||
| Exogenous expression of HIF-1 alpha promotes cardiac differentiation of embryonic stem cells | Q43179970 | ||
| Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers | Q43224443 | ||
| Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes | Q43238462 | ||
| Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: development and demonstration by ex vivo radionuclide cell labeling and in vivo tracking with positron-emission tomography. | Q43266227 | ||
| Acellular cardiac extracellular matrix as a scaffold for tissue engineering: in vitro cell support, remodeling, and biocompatibility. | Q43271430 | ||
| Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. | Q43281271 | ||
| Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces | Q43893196 | ||
| In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies. | Q43920163 | ||
| In vivo evaluation of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin). | Q44008272 | ||
| In vitro engineering of heart muscle: artificial myocardial tissue | Q44046322 | ||
| Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. | Q44135784 | ||
| Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold | Q44247957 | ||
| In vivo behavior of poly(1,3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with D,L-lactide or epsilon-caprolactone: Degradation and tissue response | Q44652547 | ||
| Mathematical treatment of autonomic oscillations | Q44864807 | ||
| Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes | Q44970476 | ||
| Murine "cardiospheres" are not a source of stem cells with cardiomyogenic potential. | Q45139526 | ||
| Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure | Q45768344 | ||
| Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. | Q45942280 | ||
| Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. | Q46036227 | ||
| Injectable biopolymers enhance angiogenesis after myocardial infarction. | Q46140198 | ||
| Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling | Q46160870 | ||
| Synthetic MMP-13 degradable ECMs based on poly(N-isopropylacrylamide-co-acrylic acid) semi-interpenetrating polymer networks. I. Degradation and cell migration | Q46169667 | ||
| A photopolymerizable hydrogel for 3-D culture of human embryonic stem cell-derived cardiomyocytes and rat neonatal cardiac cells | Q46232337 | ||
| The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction | Q46320512 | ||
| 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies | Q46537146 | ||
| Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction | Q46586639 | ||
| Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction | Q46599109 | ||
| Thermoresponsive artificial extracellular matrix for tissue engineering: hyaluronic acid bioconjugated with poly(N-isopropylacrylamide) grafts | Q30665617 | ||
| Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds | Q30846050 | ||
| Development of a biological ventricular assist device: preliminary data from a small animal model | Q31127121 | ||
| Bone marrow cell-seeded biodegradable polymeric scaffold enhances angiogenesis and improves function of the infarcted heart | Q33218216 | ||
| Poly(N-isopropylacrylamide) (PNIPAM)-grafted gelatin as thermoresponsive three-dimensional artificial extracellular matrix: molecular and formulation parameters vs. cell proliferation potential | Q33222489 | ||
| Tissue engineering of vascularized cardiac muscle from human embryonic stem cells | Q33268999 | ||
| Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue | Q33506639 | ||
| Electric field stimulation integrated into perfusion bioreactor for cardiac tissue engineering. | Q33549497 | ||
| Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC) | Q33663946 | ||
| The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction | Q33708539 | ||
| A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. | Q33755344 | ||
| Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium | Q33815153 | ||
| Cardiomyocytes can be generated from marrow stromal cells in vitro | Q33843659 | ||
| Evidence that human cardiac myocytes divide after myocardial infarction | Q33950386 | ||
| Tissue engineering of a differentiated cardiac muscle construct | Q34113271 | ||
| In situ-gelling, erodible N-isopropylacrylamide copolymers | Q34345022 | ||
| Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats | Q34355730 | ||
| Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. | Q34426397 | ||
| Decellularization of tissues and organs. | Q34499965 | ||
| Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts | Q34508414 | ||
| Differentiation of pluripotent embryonic stem cells into cardiomyocytes. | Q34778309 | ||
| Fibrin: a versatile scaffold for tissue engineering applications | Q34785791 | ||
| Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation | Q34787352 | ||
| Transplantation of a tissue-engineered human vascularized cardiac muscle | Q34994775 | ||
| Cardiac tissue engineering, ex-vivo: design principles in biomaterials and bioreactors | Q35184052 | ||
| Cells, scaffolds, and molecules for myocardial tissue engineering | Q36020144 | ||
| Human embryonic stem cell transplantation to repair the infarcted myocardium | Q36025653 | ||
| Interactive effects of surface topography and pulsatile electrical field stimulation on orientation and elongation of fibroblasts and cardiomyocytes | Q36087433 | ||
| Signaling factors in stem cell-mediated repair of infarcted myocardium | Q36181756 | ||
| Cardiopoietic programming of embryonic stem cells for tumor-free heart repair | Q36229704 | ||
| Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction | Q36349782 | ||
| Biophysical regulation during cardiac development and application to tissue engineering | Q36396902 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| Biomimetic approach to cardiac tissue engineering | Q36737037 | ||
| A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling | Q46626735 | ||
| Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. | Q46721162 | ||
| Human cord blood cells and myocardial infarction: effect of dose and route of administration on infarct size | Q47245780 | ||
| Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells | Q47254613 | ||
| Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts | Q47307807 | ||
| Hydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarction | Q47412590 | ||
| Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells | Q47607126 | ||
| Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair | Q47655125 | ||
| Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair. | Q47656260 | ||
| Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix | Q47710993 | ||
| Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study | Q47898063 | ||
| Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
| Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel | Q48641450 | ||
| Co-culture with cardiomyocytes enhanced the myogenic conversion of mesenchymal stromal cells in a dose-dependent manner. | Q50569820 | ||
| Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. | Q50640546 | ||
| Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. | Q50734767 | ||
| Cardiac pre-differentiation of human mesenchymal stem cells by electrostimulation. | Q50753273 | ||
| A novel perfusion bioreactor providing a homogenous milieu for tissue regeneration. | Q50998303 | ||
| Immobilization of aprotinin to fibrinogen as a novel method for controlling degradation of fibrin gels. | Q51025888 | ||
| Microfluidic patterning for fabrication of contractile cardiac organoids. | Q51097819 | ||
| Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. | Q51134090 | ||
| Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. | Q51168553 | ||
| Letter regarding the article by Xue et al, "Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes". | Q51375340 | ||
| Long-term evaluation of myoblast seeded patches implanted on infarcted rat hearts. | Q51565060 | ||
| Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. | Q51638429 | ||
| Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. | Q51644353 | ||
| Intravenous transplantation of mesenchymal stem cells improves cardiac performance after acute myocardial ischemia in female rats. | Q51800711 | ||
| Artificial matrix helps neonatal cardiomyocytes restore injured myocardium in rats. | Q51822210 | ||
| Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial in | Q51932160 | ||
| Improvement in hemodynamic performance, exercise capacity, inflammatory profile, and left ventricular reverse remodeling after intracoronary delivery of mesenchymal stem cells in an experimental model of pressure overload hypertrophy. | Q53500988 | ||
| Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. | Q53509060 | ||
| Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. | Q54489134 | ||
| Risk of tumorigenesis in first-in-human trials of embryonic stem cell neural derivatives: Ethics in the face of long-term uncertainty | Q56781809 | ||
| Copolymers ofN-isopropylacrylamide, HEMA-lactate and acrylic acid with time-dependent lower critical solution temperature as a bioresorbable carrier | Q57351706 | ||
| Current state of the art in myocardial tissue engineering | Q36828823 | ||
| Chitosan and its derivatives for tissue engineering applications | Q36947585 | ||
| Myocardial tissue engineering: a review. | Q37014360 | ||
| Cardiovascular cell therapy and endogenous repair | Q37060620 | ||
| Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model | Q37090990 | ||
| Rapid and dynamic alterations of gene expression profiles of adult porcine bone marrow-derived stem cell in response to hypoxia | Q37148368 | ||
| Extracellular matrix profiles in the progression to heart failure. European Young Physiologists Symposium Keynote Lecture-Bratislava 2007. | Q37199350 | ||
| Biomimetic approach to tissue engineering | Q37261143 | ||
| Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. | Q37310724 | ||
| Enhanced cell therapy for ischemic heart disease. | Q37324232 | ||
| Prevascularization of cardiac patch on the omentum improves its therapeutic outcome | Q37329635 | ||
| Increased myocyte content and mechanical function within a tissue-engineered myocardial patch following implantation. | Q37345003 | ||
| Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. | Q37401842 | ||
| Cripto-1 is required for hypoxia to induce cardiac differentiation of mouse embryonic stem cells | Q37413717 | ||
| Scaffold-free human cardiac tissue patch created from embryonic stem cells | Q37414585 | ||
| Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy | Q37420332 | ||
| Cardiac regeneration by progenitor cells: what is it known as and what is it still to be known as? | Q37438026 | ||
| Electrical stimulation of human embryonic stem cells: cardiac differentiation and the generation of reactive oxygen species | Q37455698 | ||
| Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. | Q37705622 | ||
| Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices | Q37772818 | ||
| Molecular physiology of cardiac regeneration | Q37808269 | ||
| Methods for Human Embryonic Stem Cells Derived Cardiomyocytes Cultivation, Genetic Manipulation, and Transplantation | Q39672330 | ||
| An elastomeric patch derived from poly(glycerol sebacate) for delivery of embryonic stem cells to the heart. | Q39740129 | ||
| Cardiomyocyte differentiation of human induced pluripotent stem cells | Q39794134 | ||
| In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan-doxorubicin conjugates | Q39857749 | ||
| Toward the development of partially biodegradable and injectable thermoresponsive hydrogels for potential biomedical applications | Q39880817 | ||
| Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel | Q39908073 | ||
| Preparation of cardiac extracellular matrix from an intact porcine heart | Q39952932 | ||
| Generation of functional murine cardiac myocytes from induced pluripotent stem cells | Q39961528 | ||
| In vivo optical bioluminescence imaging of collagen-supported cardiac cell grafts | Q40161779 | ||
| Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. | Q40173892 | ||
| Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. | Q40479961 | ||
| Induced pluripotent stem cells and senescence: learning the biology to improve the technology | Q40507894 | ||
| Stable benefit of embryonic stem cell therapy in myocardial infarction. | Q40531312 | ||
| A novel small animal model of left ventricular tissue engineering | Q40661638 | ||
| Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies | Q41061514 | ||
| Human spongiosa mesenchymal stem cells fail to generate cardiomyocytes in vitro | Q41843371 | ||
| Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering | Q41969553 | ||
| Percutaneous cell delivery into the heart using hydrogels polymerizing in situ | Q42607880 | ||
| A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. | Q42688498 | ||
| Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair | Q42794686 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1055-1077 | |
| P577 | publication date | 2011-05-05 | |
| P1433 | published in | Expert Opinion on Biological Therapy | Q5421201 |
| P1476 | title | Engineering cell platforms for myocardial regeneration | |
| P478 | volume | 11 |
| Q58577896 | A Thin Layer of Decellularized Porcine Myocardium for Cell Delivery |
| Q36947690 | A mathematical model for analyzing the elasticity, viscosity, and failure of soft tissue: comparison of native and decellularized porcine cardiac extracellular matrix for tissue engineering |
| Q36800040 | Analysis of stromal cell secretomes reveals a critical role for stromal cell-derived hepatocyte growth factor and fibronectin in angiogenesis |
| Q41241313 | Application of biotechnology in myocardial regeneration-tissue engineering triad: cells, scaffolds, and signaling molecules |
| Q38543476 | Bioengineering methods for myocardial regeneration |
| Q50421075 | Biological and mechanical interplay at the Macro- and Microscales Modulates the Cell-Niche Fate. |
| Q33622487 | Biomechanics of cardiac electromechanical coupling and mechanoelectric feedback |
| Q92728117 | Cardiac fibrosis: potential therapeutic targets |
| Q38172390 | Cardiac tissue engineering: renewing the arsenal for the battle against heart disease |
| Q27693850 | Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine |
| Q37945291 | Fibrin as a scaffold for cardiac tissue engineering. |
| Q35662994 | In vitro comparative study of two decellularization protocols in search of an optimal myocardial scaffold for recellularization |
| Q26775715 | In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin' |
| Q30527783 | Ischemic preconditioning promotes intrinsic vascularization and enhances survival of implanted cells in an in vivo tissue engineering model. |
| Q37378396 | Micro- and Macrostructured PLGA/Gelatin Scaffolds Promote Early Cardiogenic Commitment of Human Mesenchymal Stem Cells In Vitro |
| Q36477618 | Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease |
| Q35589725 | Pushing the envelope in tissue engineering: ex vivo production of thick vascularized cardiac extracellular matrix constructs. |
| Q45290478 | Rebuilding the infarcted heart with noncellular material |
| Q38682836 | Restoring the biophysical properties of decellularized patches through recellularization |
| Q36452973 | Secreted proteins as a fundamental source for biomarker discovery |
| Q40083319 | Surface-modified polymers for cardiac tissue engineering. |
| Q36870389 | The acellular myocardial flap: a novel extracellular matrix scaffold enriched with patent microvascular networks and biocompatible cell niches |
| Q36294610 | Thick acellular heart extracellular matrix with inherent vasculature: a potential platform for myocardial tissue regeneration |
| Q33862440 | Use of myocardial matrix in a chitosan-based full-thickness heart patch |
Search more.